Back to 
FMR LLC
FMR LLC
XLRNShowing 0 of 10 quarters
Position history for FMR LLC's holdings in ACCELERON PHARMA INC
As of its Q3 2021 13F, FMR held 2,072,735 shares of XLRN (Acceleron Pharma), worth $356.7M. FMR's 13F filings listed XLRN from Q3 2019 to Q3 2021, 9 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of XLRN: PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC